DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical's Proposed Business Combination with Zoar Limited

Stock Information for DSS Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About DSS Inc.

DSS, Inc. Launches DSS Robotics to Bring AI-Powered Automation to Enterprise Operations
DSS, Inc. Announces Decision Not to Proceed with Proposed Public Offering
DSS, Inc. Announces Launch of Proposed Public Offering
American Fusion Inc. (OTC: AMFN) Appoints Asian Financial Markets and Digital Assets Executive Samson Lee as Independent Director
DSS, Inc. Withdraws Registration Statement
DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing
DSS, Inc. Letter to Shareholders
DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.